BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Filing Type: 6-K
Filing Date: 20060607

Documents

FACING PAGE
6-K
PRESS RELEASE: BETAFERON APPROVED IN EUROPE AS FIRST-LINE TREATMENT OF MULTIPLE SCLEROSIS
EX-1
DISCLAIMER
EX-2
SIGNATURES
EX-3